English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 114104/145136 (79%)
Visitors : 52288932      Online Users : 420
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/100971


    Title: 我國專利法及藥事法上試驗例外之研究
    Other Titles: The Research of Experimental Use Exception on Patent Law and Pharmaceutical Affairs Act
    Authors: 孫小萍
    Sun, Hsiao-Ping
    Keywords: 專利權;專利法;藥事法;試驗例外;Bolar 例外;Hatch-Waxman 法案;專利藥;學名藥
    Patent Rights;Patent Law;Pharmaceutical Affairs Act;Experimental Use Exception;Bolar Exception;Hatch-Waxman Act;Brand Name Drugs;Generic Drugs
    Date: 2005-10
    Issue Date: 2016-08-31 16:34:44 (UTC+8)
    Abstract: 「試驗例外」條款在各國司法實務運作上，最常被引起爭論者向來集中在處方藥市場中專利藥廠與學名藥廠間之競爭議題。雖然我國專利法與其他國家一樣也有試驗例外條款，但其中要件嚴格限定為「非營利行為」，此乃各國立法例少見；另外，民國九十四年二月五日甫增訂生效之藥事法第四十條之二第五項關於「Bolar例外」之規定，又因立法用語不當造成實務運用之困擾。由於我國本土藥廠向來仰賴生產學名藥為大宗，國內藥廠在如此嚴格的法規環境下實難與國外原廠相提並論。本文將先從分析國際規範及各國案例著手，繼之藉國內立法資料及司法案例探討我國近日之相關修法內容及實務見解，最後思考如何在不違反WTO架構下之義務，同時兼顧公共利益與鼓勵研發創新，對國內提出相關修法建議。
    In the practice of experimental use exception doctrine, public debates always focus on the impact of the measure on pharmaceutical products. The experimental use exception doctrine in Taiwan is a very narrow one. To fall within this exception on patent law, the use has to be one that is without profit-seeking acts. In addition, the President’s Promulgation on Pharmaceutical Affairs Act Amendment in 2/5/2005 is to revise and augment the Article 40-2. According to article 40-2(5), the effect of a new drug invention patent right shall not extend to the practice before submitting a new drug application for research, educational or experimental purposes. This is so- called ”Bolar exception “. Because of the haste of its legislation, the Bolar exception rule in Taiwan is not practical. Therefore, this article attempts to set forth some opinions of the draft amendments. First, this article introduces the case law of foreign countries. Then, this article interprets the contents of patent law and pharmaceutical affairs act in Taiwan, and comments on a related case of Taiwan Taipei District Court. Finally, this article reaches some conclusions of the proposal for the draft amendments.
    Relation: 政大智慧財產評論, 3(2), 1-32
    NCCU Intellectual Property Review
    Data Type: article
    Appears in Collections:[智慧財產評論] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML2473View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback